affiliation not provided to SSRN
non-small cell lung cancer, radiotherapy, durvalumab, oligorecurrence, recurrence pattern, chemoradiotherapy, salvage therapy, SBRT, PACIFICnon-small cell lung cancer, radiotherapy, durvalumab, oligorecurrence, recurrence pattern, chemoradiotherapy